DEVELOPMENT OF A NOVEL AAV VECTOR CAPSID OPTIMIZED FOR OA GENE THERAPY

$4,559,445FY2019Defense Health AgencyDOD

University Of Florida, Gainesville FL

Investigators

View source on USAspending →